Performance of Screening Strategies for Latent Tuberculosis Infection in Patients with Inflammatory Bowel Disease: Results from the ENEIDA Registry of GETECCU

(1) Aims: Patients receiving antitumor necrosis factor (anti-TNF) therapy are at risk of developing tuberculosis (TB), usually due to the reactivation of a latent TB infection (LTBI). LTBI screening and treatment decreases the risk of TB. This study evaluated the diagnostic performance of different...

Full description

Bibliographic Details
Main Authors: Sabino Riestra, Carlos Taxonera, Yamile Zabana, Daniel Carpio, María Chaparro, Jesús Barrio, Montserrat Rivero, Antonio López-Sanroman, María Esteve, Ruth de Francisco, Guillermo Bastida, Santiago García-López, Miriam Mañosa, María Dolores Martin-Arranz, José Lázaro Pérez-Calle, Jordi Guardiola, Fernando Muñoz, Laura Arranz, José Luis Cabriada, Mariana Fe García-Sepulcre, Mercè Navarro, Miguel Ángel Montoro-Huguet, Elena Ricart, Fernando Bermejo, Xavier Calvet, Marta Piqueras, Esther Garcia-Planella, Lucía Márquez, Miguel Mínguez, Manuel Van Domselar, Luis Bujanda, Xavier Aldeguer, Beatriz Sicilia, Eva Iglesias, Guillermo Alcaín, Isabel Pérez-Martínez, Valeria Rolle, Andrés Castaño-García, Javier P. Gisbert, Eugeni Domènech, on behalf of the ENEIDA registry from GETECCU
Format: Article
Language:English
Published: MDPI AG 2022-07-01
Series:Journal of Clinical Medicine
Subjects:
Online Access:https://www.mdpi.com/2077-0383/11/13/3915